Φορτώνει......
Androgen receptor targeted therapies in castration‐resistant prostate cancer: Bench to clinic
The androgen receptor is a transcription factor and validated therapeutic target for prostate cancer. Androgen deprivation therapy remains the gold standard treatment, but it is not curative, and eventually the disease will return as lethal castration‐resistant prostate cancer. There have been impro...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Int J Urol |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6680212/ https://ncbi.nlm.nih.gov/pubmed/27302572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/iju.13137 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|